Insights into the Future Growth Potential of the Induced Pluripotent Stem Cell (iPSC) Market 2024-2033
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Expected Expansion Rate of the Induced Pluripotent Stem Cell (iPSC) Market in the 2024-2033 Forecast?
The market size for induced pluripotent stem cells (ipsc) has been rapidly escalating in recent years. It is projected to expand from $2.97 billion in 2023 to $3.29 billion in 2024, showcasing a compound annual growth rate (CAGR) of 10.8%. The notable growth observed in the previous period can be linked to factors such as increased healthcare spending, higher funding, enhanced understanding of the therapeutic potential of stem cell products, the employment of induced pluripotent stem cell (ipsc) in drug discovery, growing demand for customized medicine, and the cost-effective advantages of ipsc in the realm of drug discovery.
The market for induced pluripotent stem cells (ipsc) is predicted to experience swift expansion in the coming years, reaching a worth of $4.81 billion in 2028, with a 10.0% compound annual growth rate. This growth in the projected period can be linked to factors such as the increasing occurrence of chronic and genetic diseases, advancements in genomic projects, creation of ipsc-based disease models, governmental support, and rapid technological advancements. Key trends for the future include the use of pluripotent stem cells for Parkinson’s disease (pd), strategic alliances and partnerships, creation of ipsc-derived nk cells, utilization of induced pluripotent stem cells (ipsc) for cellular therapy, investment in the research and development of regenerative medicine, creation of an ipsc expansion medium, personalization of ipsc, and the use of pluripotent stem cells in Type I diabetes treatment.
Claim Your Free Sample of the Global Induced Pluripotent Stem Cell (iPSC) Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp
What Factors Are Catalyzing the Growth of the induced pluripotent stem cell (ipsc) Market?
The increase in persistent diseases is a key factor propelling the induced pluripotent stem cell market’s growth. Chronic conditions such as heart ailment, cancer, stroke, and diabetes are treatable with Induced pluripotent stem cells. These stem cells are derived from tissues of either children or adults and are genetically altered to function like embryonic stem cells. The Partnership to Fight Chronic Disorder (PFCD) report revealed that 45% of the 133 million Americans had a minimum of one chronic disease. Furthermore, it was predicted that chronic diseases cause 1.7 million or 70% of U.S. deaths, and these could be regulated through induced pluripotent stem cell therapies. This surge in chronic disease incidences boosts the requirement for induced pluripotent stem cell treatments.
Which Segments Are Important in the Induced Pluripotent Stem Cell (iPSC) Market Landscape?
1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types
2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy
3) By End-User: Hospitals, Research Laboratories
What Are the Groundbreaking Trends in the Induced Pluripotent Stem Cell (iPSC) Market?
Firms in the Induced Pluripotent stem cell market are seeking strategic alliances and collaborations that will assist them in penetrating new territories and broadening their product offerings. For instance, Bristol Myers Squibb and Century Therapeutics initiated a strategic collaboration in January 2022 to create iPSC-derived allogenic cell treatments for acute myeloid leukemia and multiple myeloma. Additionally, in May 2022, Evotec and Sernova revealed a strategic partnership to create an iPSC-based beta cell replacement therapy to manage type 1 and type 2 diabetes.
Order Now for Fast Delivery of Your Induced Pluripotent Stem Cell (iPSC) Market Report!
https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report
What Are the Key Regions Powering Growth in the Induced Pluripotent Stem Cell (iPSC) Market?
North America was the largest region in the induced pluripotent stem cell (iPSC) market in 2023. Western Europe was the second largest region in the global induced pluripotent stem cell (iPSC) market share. The regions covered in the induced pluripotent stem cell (ipsc) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Induced Pluripotent Stem Cell (iPSC) Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the induced pluripotent stem cell (ipsc) market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Induced Pluripotent Stem Cell (iPSC) Market Include
1. Induced Pluripotent Stem Cell (iPSC) Market Executive Summary
2. Induced Pluripotent Stem Cell (iPSC) Market Segments
3. Induced Pluripotent Stem Cell (iPSC) Market Size And Template Market Growth Rate
4. Key Induced Pluripotent Stem Cell (iPSC) Market Trends
5. Major Induced Pluripotent Stem Cell (iPSC) Market Drivers
……
25. Key Mergers And Acquisitions In The Induced Pluripotent Stem Cell (iPSC) Market
26. Top Induced Pluripotent Stem Cell (iPSC) Companies
27. Induced Pluripotent Stem Cell (iPSC) Market Opportunities And Strategies
28. Induced Pluripotent Stem Cell (iPSC) Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Museums, Historical Sites, Zoos, And Parks Global Market Report 2024
E-Sports Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/e-sports-global-market-report
Cell Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
